EXCELLTHERA
ExCellThera is an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. ExCellThera’s lead technology, ECT-001, combines a proprietary small molecule, UM171, and an optimized culture system. In pursuit of better treatments for patients, the company is building out its portfolio of products, as well as supporting best-in-class clinical trials.
EXCELLTHERA
Industry:
Biotechnology Therapeutics
Founded:
2015-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.excellthera.com
Total Employee:
1+
Status:
Active
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Global Site Tag
Similar Organizations
Rasna Therapeutics
It is a development stage biotechnology company
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Neuroene Therapeutics
Neuroene Therapeutics is a startup biotechnology company.
Nano Cures
Nano Cures is clinical-stage biotechnology and infectious disease immunity platform company.
Neuraly
Neuraly is a startup biotech company.
NovaBiotics
NovaBiotics Ltd is a clinical-stage biotechnology company.
VBL Therapeutics
VBL Therapeutics is a clinical-stage platform company developing targeted therapies for immune-inflammatory diseases.
Mara Renewables
Mara Renewables Corporation (Mara) is the leading Canadian biotechnology company.
Micronoma
Micronoma is a cancer detection biotech company.
Modulus Therapeutics
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
MaveriX Oncology
MaveriX Oncology is a globally-orientated biotechnology company.
MaxiVAX
MaxiVAX is a Swiss clinical-stage biotechnology company.
Metera Pharmaceuticals
Metera Pharmaceuticals is a preclinical stage biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
LinKinVax
LinKinVax operates as a clinical-stage biotechnology company.
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company.
Amarna Therapeutics
Amarna Therapeutics is a privately held European biotechnology company.
Atavistik Bio
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Arch Oncology
Arch Oncology is an immuno-oncology company
Origin
Origin is a privately held, clinical-stage biotechnology company.
Alderaan Biotechnology
Alderaan is a biotechnology company.
Enthera
Enthera is a biotech company whose mission is to find new therapeutic approaches to treat diabetes and gastrointestinal complication.
Enterin
Philadelphia-based biotechnology company .
ExploraMed
ExploraMed is a venture-backed medical technology incubation company.
ET Healthcare
ET Healthcare is an in vitro diagnostic technology company.
Escient Pharmaceuticals
Escient Pharmaceuticals is a privately held biotechnology company.
Excellims Corporation
Excellims Corporation is a biotechnology company.
EpicentRx Inc
EpicentRx Inc is a clinical-stage immuno-oncology company.
Falcon Therapeutics
A Chapel Hill-based biotechnology company.
TikoMed
TikoMed is a biotechnology company.
Tactiva Therapeutics
Tactiva Therapeutics is a development stage immuno-oncology company
Turnstone Biologics
Turnstone Biologics is a privately-held clinical stage biotech company.
January Therapeutics
January Therapeutics is a San Diego-based biotechnology company.
Kovina Therapeutics
Kovina Therapeutics operates as a pre-clinical biotechnology company.
10xBio
10xBio, LLC, a privately-held biotechnology company
Septerna
Septerna is a biotechnology company.
Seraxis
Seraxis is a privately owned biotechnology company.
SomaGenics
SomaGenics is a privately held biotechnology company.
DNALite Therapeutics
DNALite Therapeutics is an early-stage preclinical biotechnology company.
Decoy Therapeutics
Decoy Therapeutics is a preclinical stage biotech company.
Danimer Scientific
Danimer Scientific is a biotechnology company that makes bioplastics used in disposable container coatings, packaging, and other products.
Dymicron
Dymicron is an innovation-driven medical technology company.
Haima Therapeutics
Haima Therapeutics is a pre-clinical stage biotechnology company.
Intrepida Bio
IntrepidaBio is a preclinical biotechnology company.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Origin Agritech
Origin Agritech is a leading agricultural biotechnology company.
Canadian Utilities
Canadian Utilities is a biotechnology company.
Cellenkos
Cellenkos is a clinical stage biotech company.
Cell Therapy
Cell Therapy is a British based biotech company .
Calimmune
Calimmune is a clinical-stage gene therapy company.
CytoNiche
CytoNiche is a 3D bionic cell technology company.
Clarametyx Biosciences
Clarametyx Biosciences is a late preclinical stage biotechnology company.
Celltheon
Celltheon is a cell line development and expression technologies company.
Cloudbreak Therapeutics
Cloudbreak Therapeutics is a clinical stage biotechnology company
Propagenix
Propagenix Inc. is biotech company.
panCELLa
Toronto based biotechnology company.
Privo Technologies
Privo Technologies is a development-stage biotechnology company located just outside Boston, MA.
Pulmair Medical
Pulmair Medical is a provider of biotechnology services.
PhagePro
PhagePro is an early-stage biotechnology therapeutics company.
Current Employees Featured
Founder
Official Site Inspections
http://www.excellthera.com Semrush global rank: 9.2 M Semrush visits lastest month: 195
- Host name: 249.165.69.216.host.secureserver.net
- IP address: 216.69.165.249
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ExCellThera"
About - ExCellThera
Learn about our mission, team, and commitment to advancing regenerative medicine. Explore our journey towards pioneering innovative cell therapy solutions.See details»
ExCellThera - Crunchbase Company Profile & Funding
ExCellThera is an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. ExCellThera’s lead technology, ECT-001, combines a …See details»
ExCellThera - LinkedIn
ExCellThera will be participating in two investor conferences in January: #BiotechShowcase, presentation on January 8 at 4:45 PT and @BRileyFinancial 4th Annual Oncology …See details»
ExCellThera Announces International Non-proprietary Name and …
MONTREAL, June 4, 2024 – ExCellThera Inc. (ExCellThera), a world leader in enhanced blood stem cell expansion and therapies, announced today that UM171 Cell Therapy has been …See details»
Catching up with ExCellThera and co-founder Guy …
Aug 17, 2022 Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award …See details»
ExCellThera Company Profile 2024: Valuation, Funding …
ExCellThera General Information Description. Developer of a cell therapy platform designed to address blood cancers. The company offers UM171 Cell Therapy (dorocubicel) utilizing genetically engineered hematopoietic stem cells focused …See details»
ExCellThera Company Profile - Office Locations, Competitors
ExCellThera is a company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. It provides ECT-001, a technology that combines a …See details»
ExCellThera - University of Toronto Entrepreneurship
ExCellThera is an advanced clinical stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use.See details»
ExCellThera - Contacts, Employees, Board Members, Advisors
ExCellThera has 3 current employee profiles, including Scientific Co-Founder, Chief Executive Officer & Chief Scientific Officer Guy Sauvageau. Contacts Edit Contacts SectionSee details»
ExCellThera to establish stem cell bioproduction facility thanks to ...
Nov 13, 2020 ExCellThera Inc., a company focusing on cellular and molecular medicine at the advanced clinical stage, will receive a repayable contribution of up to $4 million from Canada …See details»
ExCellThera announces oral presentation of new data on UM171 …
Nov 4, 2022 ExCellThera is a world leader in blood stem cell expansion and rejuvenation. ExCellThera’s lead proprietary molecule, UM171, has become the standard for hematopoietic …See details»
ExCellThera Can Improve Patient Access to Cord Blood Transplants
ExCellThera has developed an expanded cord blood product called ECT-001 that is based culturing cord blood with the small molecule UM171. The ExCellThera ECT-001 product is …See details»
ExCellThera announces 100th patient treated with UM171 …
MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary …See details»
ExCellThera to present at the 2022 Cell Therapy Transplant Canada ...
MONTRÉAL, June 13, 2022 – ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and …See details»
ExCellThera announces new publication showing its ECT-001
Apr 13, 2022 ExCellThera is a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and engineer various cell lines for use in …See details»
ExCellThera announces 100th patient treated with - GlobeNewswire
MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary …See details»
News - ExCellThera
Mar 27, 2024 June 4, 2024. ExCellThera Announces International Non-proprietary Name and New Orphan Drug Designation for UM171 Cell Therapy – UM171 Cell Therapy has been …See details»
ExCellThera announces completion of Phase 2 clinical trials for …
MONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today the completion of …See details»
Pipeline - ExCellThera
Exploring Innovation | ExcellThera Pipeline - Dive into our promising pipeline of cutting-edge regenerative medicine solutions. Discover the future of healthcare through our research and …See details»